SCHEMBL4284583

SCHEMBL4284583

S=C=Nc1ccc(Br)c(Br)c1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
ABCB11 O95342 1/20 0.36
NR3C1 P04150 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADRA2A P08913 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ADRA2C P18825 1/20 0.36
MAOA P21397 1/20 0.36
DRD1 P21728 1/20 0.36
SLC6A4 P31645 1/20 0.36
HTR2B P41595 1/20 0.36
CCR2 P41597 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MIF P14174 1/20 0.34
APLNR P35414 1/20 0.32
CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9304725 0.79 ALDH1A1 (0.38) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL4285629 0.77 CYP3A4 (0.40) ALDH1A1CYP3A4HPGDTDP1
SCHEMBL2976682 0.72 ALDH1A1 (0.55) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL6153417 0.71 HSP90AA1 (0.37) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL188261 0.71 ALOX15 (0.38) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL1022261 0.70 ALDH1A1 (0.52) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL30507607 0.70 ALDH1A1 (0.52) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL11718845 0.70 ALDH1A1 (0.61) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL1093861 0.70 ABCB11 (0.32) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL3367043 0.68 MIF (0.34) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203877-A1 X-RAY-DENSE CONJUGATE EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINKUM 2009-08-13 US claimed
EP-2046392-A2 RADIODENSE CONJUGATE Eberhard-Karls-Universität Tübingen Universitätsklinikum (DE) 2009-04-15 EP claimed
WO-2008012102-A2 RADIODENSE CONJUGATE EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) 2008-01-31 WO claimed
US-20090203877-A1 X-RAY-DENSE CONJUGATE EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINKUM 2009-08-13 US disclosed
EP-2046392-A2 RADIODENSE CONJUGATE Eberhard-Karls-Universität Tübingen Universitätsklinikum (DE) 2009-04-15 EP disclosed
WO-2008012102-A2 RADIODENSE CONJUGATE EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203877-A1 X-RAY-DENSE CONJUGATE FCGR3B, KLK3, XPA ALDH1A1 2704/4885ABCB11 1245/4885NR3C1 1496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.